Personalized Behavioral Nutrition for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it does exclude people on a diet different from the ADA recommended diet, so dietary changes might be required.
What data supports the effectiveness of this treatment for Type 2 Diabetes?
Research shows that personalized nutrition therapy, which considers individual health goals and cultural preferences, can improve blood sugar control in people with diabetes. Additionally, culturally tailored dietary interventions have been effective in improving nutritional knowledge and blood glucose levels, especially when adapted to specific cultural dietary patterns.12345
Is Personalized Behavioral Nutrition safe for humans?
What makes the Personalized Behavioral Nutrition treatment unique for managing Type 2 Diabetes?
The Personalized Behavioral Nutrition treatment is unique because it tailors dietary interventions to individual needs using a machine-learning algorithm to predict how different foods affect blood sugar levels, unlike the standard 'one-size-fits-all' approach. It also incorporates cultural factors and uses mobile health technology to support behavior change, making it more adaptable to diverse lifestyles and preferences.236710
What is the purpose of this trial?
The rapid growth rate and unique challenges as a new immigrant group call for a better understanding of the social and health needs of the older Asian Americans (AAs) population. Overwhelming numbers of AAs, a fast-growing first-generation immigrant group, suffer from type 2 diabetes (T2D) and its consequences of poorly controlled blood glucose. For the older AAs, there are higher prevalence rates, worse diabetes control, and higher rates of complications due to limited English proficiency and health literacy. Despite the evidence concerning the effects of dietary interventions on glycemic control by well-controlled feeding studies in mainstream Americans, a lack of clinical trials of culturally tailored interventions often imposes serious barriers to translate and implement such fruitful and innovative approaches in individuals from ethnic minority communities such as AAs.The proposed study will use a randomized, controlled design with a sample of 60 AAs aged 65 years or older. Metabolomics methodologies will be incorporated into this research to provide a global picture of metabolites' responses to personalized behavioral nutrition (PBN) intervention. The study results will obtain the necessary information to conduct a meaningful community-based clinical trial to test the effectiveness of PBN in improving dietary patterns and glycemic control in older AAs.
Research Team
Jisook Ko, PhD
Principal Investigator
The University of Texas Health Science Center at San Antonio
Eligibility Criteria
This trial is for older Asian Americans aged 65 or above with type 2 diabetes, an A1C level of at least 7.5%, living in Bexar County, and who own a smartphone. Participants must be willing to engage fully in the study and not be on any special diets other than the ADA recommended diet.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 4-week personalized behavioral nutrition intervention with digital self-monitoring for diet and blood glucose, and diabetes nutrition education.
Follow-up
Participants are monitored for changes in glycemic control, lipids profiles, weight, and metabolites profiles.
Treatment Details
Interventions
- ADA-based nutrition education with digital self-monitoring
- Personalized Behavioral Nutrition (PBN) intervention group
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center at San Antonio
Lead Sponsor
Asian Resource Center for Minority Aging Research (RCMAR)
Collaborator
The Rutgers Asian Resource Center for Minority Aging Research (RCMAR)
Collaborator